Attached files

file filename
EX-10.12 - EXHIBIT 10.12 - Zander Therapeutics, Incex10_12.htm
EX-23.1 - EXHIBIT 23.1 - Zander Therapeutics, Incex23_1.htm
EX-5.1 - EXHIBIT 5.1 - Zander Therapeutics, Incex5_1.htm
EX-14.1 - EXHIBIT 14.1 - Zander Therapeutics, Incex14_1.htm
EX-10.14 - EXHIBIT 10.14 - Zander Therapeutics, Incex10_14.htm
EX-10.13 - EXHIBIT 10.13 - Zander Therapeutics, Incex10_13.htm
EX-10.11 - EXHIBIT 10.11 - Zander Therapeutics, Incex10_11.htm
EX-10.10 - EXHIBIT 10.10 - Zander Therapeutics, Incex10_10.htm
EX-10.9 - EXHIBIT 10.9 - Zander Therapeutics, Incex10_9.htm
EX-10.8 - EXHIBIT 10.8 - Zander Therapeutics, Incex10_8.htm
EX-10.7 - EXHIBIT 10.7 - Zander Therapeutics, Incex10_7.htm
EX-10.6 - EXHIBIT 10.6 - Zander Therapeutics, Incex10_6.htm
EX-10.5 - EXHIBIT 10.5 - Zander Therapeutics, Incex10_5.htm
EX-10.4 - EXHIBIT 10.4 - Zander Therapeutics, Incex10_4.htm
EX-10.3 - EXHIBIT 10.3 - Zander Therapeutics, Incex10_3.htm
EX-10.2 - EXHIBIT 10.2 - Zander Therapeutics, Incex10_2.htm
EX-10.1 - EXHIBIT 10.1 - Zander Therapeutics, Incex10_1.htm
EX-3.I.5 - EXHIBIIT 3(I)(5) - Zander Therapeutics, Incex3i5.htm
EX-3.I.4 - EXHIBIT 3(I)(4) - Zander Therapeutics, Incex3i4.htm
EX-3.I.3 - EXHIBIT 3(I)(3) - Zander Therapeutics, Incex3i3.htm
EX-3.I.2 - EXHIBIT 3(I)(2) - Zander Therapeutics, Incex3i2.htm
EX-3.I - EXHIBIT 3(I) - Zander Therapeutics, Incex3i.htm
S-1 - FORM S-1 - Zander Therapeutics, Inczander092817forms1.htm

 exhibit 23.2

 

 

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

 

We consent to the use, in the statement on Form S-1 of Zander Therapeutics, Inc., of our report dated September 5, 2017 on our audit of the financial statements of Zander Therapeutics, Inc. as of June 30, 2017 and June 30, 2016, and the related statements of operations, stockholders’ equity and cash flows for the years ended June 30, 2017 and June 30, 2016, and the reference to us under the caption “Experts”.

 

 

 

 

 

 

 

 

/s/ AMC Auditing

 

AMC Auditing

Las Vegas, Nevada

September 26, 2017